AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

AdvancedAdvT Limited

Regulatory Filings Jan 6, 2022

10416_rns_2022-01-06_bd492a6b-dfad-426c-84a4-617f4847707b.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 6466X

Advancedadvt Limited

06 January 2022

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

6 JANUARY 2022

LEI: 254900WYO35S1T334A28

AdvancedAdvT Limited

(the "Company")

Rule 2.9 announcement

In accordance with Rule 2.9 of the City Code on Takeovers and Mergers, the Board of AdvancedAdvT Limited (LSE: ADVT) confirms that as at the close of business on 5 January 2022 its issued share capital consisted of 133,200,000 ordinary shares of no par value each with voting rights, 2 sponsor shares of no par value each with no voting rights and no shares held in treasury.

The International Securities Identification Number for the Company's ordinary shares is VGG0103J1075.

Enquiries:  

Company Secretary

Antoinette Vanderpuije   020 7004 2743

Meare Consulting

Adrian Duffield     07990 858548

Further information on the Company can be found on its website at www.advancedadvt.com. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website or any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a regulatory information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RTTUNSKRUUUARRR

Talk to a Data Expert

Have a question? We'll get back to you promptly.